Variable | Frequency | Median survival | Log Rank |
---|---|---|---|
Gender | N.S. | ||
Female | 146 | 2.9 M | |
Male | 193 | 2.1 M | |
Age | p = 0.0002 | ||
30–49 | 37 | 7.0 M | |
50–69 | 184 | 2.5 M | |
70–90 | 118 | 1.5 M | |
KPS | p = 0.0001 | ||
90–100% | 94 | 5.2 M | |
70–80% | 138 | 2.5 M | |
< 70% | 107 | 1.2 M | |
Time of occurrence | N.S. | ||
Synchronous with primary | 130 | 2.8 M | |
After primary | 209 | 2.4 M | |
Hospitalization | p = 0.0001 | ||
Yes | 126 | 0.9 M | |
No | 213 | 3.5 M | |
Number of brain metastases | p = 0.031 | ||
Singular/solitary | 65 | 3.7 M | |
≤ 3 | 75 | 2.6 M | |
> 3 or bulk | 199 | 2.3 M | |
Primary disease status | p = 0.0244 | ||
Controlled primary | 64 | 3.8 M | |
Uncontrolled primary | 275 | 2.3 M | |
Tumor site (3 most common and other) | N.S. | ||
NSCLC | 148 | 2.5 M | |
SCLC | 59 | 2.4 M | |
Breast cancer | 47 | 2.9 M | |
Other | 85 |